Cargando…
Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates
For many years, cell-surface glycans (in particular, Tumor-Associated Carbohydrate Antigens, TACAs) have been the target of both passive and active anticancer immunotherapeutic design. Recent advances in immunotherapy as a treatment for a variety of malignancies has revolutionized anti-tumor treatme...
Autor principal: | Barchi, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006936/ https://www.ncbi.nlm.nih.gov/pubmed/35432351 http://dx.doi.org/10.3389/fimmu.2022.852147 |
Ejemplares similares
-
Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022) -
Glycoconjugates in Host-Helminth Interactions
por: Prasanphanich, Nina Salinger, et al.
Publicado: (2013) -
Recent Advances in the Chemistry of Glycoconjugate Amphiphiles
por: Latxague, Laurent, et al.
Publicado: (2018) -
Application of lipid-based nanoparticles in cancer immunotherapy
por: Zhang, Zhongkun, et al.
Publicado: (2022) -
Recent advances on smart glycoconjugate vaccines in infections and cancer
por: Anderluh, Marko, et al.
Publicado: (2021)